SUSQUEHANNA INTERNATIONAL GROUP, LLP - AKCEA THERAPEUTICS INC ownership

AKCEA THERAPEUTICS INC's ticker is AKCA and the CUSIP is 00972L107. A total of 86 filers reported holding AKCEA THERAPEUTICS INC in Q2 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.0%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of AKCEA THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$207,000
-67.4%
11,400
-75.4%
0.00%
Q2 2020$634,000
-47.5%
46,300
-45.2%
0.00%
Q1 2020$1,207,000
-48.8%
84,430
-39.4%
0.00%
Q4 2019$2,359,000
-49.8%
139,294
-54.4%
0.00%
-100.0%
Q3 2019$4,697,000
-77.8%
305,200
-66.2%
0.00%
-33.3%
Q2 2019$21,176,000
+136.0%
903,042
+185.1%
0.00%0.0%
Q1 2019$8,972,000
+31.3%
316,700
+39.7%
0.00%
+50.0%
Q4 2018$6,833,000
-11.9%
226,700
+2.3%
0.00%0.0%
Q3 2018$7,760,000
+443.8%
221,600
+268.1%
0.00%
Q2 2018$1,427,000
+21.1%
60,200
+30.9%
0.00%
Q1 2018$1,178,00046,0000.00%
Other shareholders
AKCEA THERAPEUTICS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Iguana Healthcare Management, LLC 100,000$1,736,0001.13%
BB BIOTECH AG 1,248,650$21,677,0000.61%
Virtus ETF Advisers LLC 18,071$314,0000.39%
Eventide Asset Management 420,000$7,291,0000.38%
Granahan Investment Management 194,376$3,374,0000.26%
ALTRINSIC GLOBAL ADVISORS LLC 150,000$2,604,0000.10%
Candriam S.C.A. 114,571$1,990,0000.03%
ARDSLEY ADVISORY PARTNERS LP 15,000$260,0000.03%
Delpha Capital Management, LLC 1,521$26,0000.03%
FMR LLC 9,981,244$173,274,0000.02%
View complete list of AKCEA THERAPEUTICS INC shareholders